Indefinite Delivery Contract HHSD200201562103I

This federal Indefinite Delivery Contract (IDC) award to Pfizer Inc. is for the procurement of COVID-19 adult vaccines on behalf of the Centers for Disease Control and Prevention (CDC). The multiple-award contract has a total ceiling value of $498,550,000 and a period of performance through September 30, 2025. As the prime contractor, Pfizer will be responsible for delivering a range of pharmaceutical products to support federal healthcare programs, including the Vaccines for Children (VFC)...

This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. to purchase a variety of pediatric vaccines for the Vaccines for Children (VFC) program. The $1.5 billion contract has a period of performance from April 1, 2023 to March 31, 2024. The contract will procure a minimum of 100 doses up to maximum quantities ranging from 100,000 to 13 million doses for 21...

The federal contract IDV award is for the delivery of adult vaccines to the Centers for Disease Control and Prevention (CDC). The prime contractor is Pfizer Inc., a global pharmaceutical corporation headquartered in New York. The contract has a total ceiling value of $117,849,500.00 and a period of performance from July 1, 2025, through June 30, 2026. This multiple-award IDV contract is not set aside for any specific business size or type. Pfizer, as a large manufacturer of goods, will provide a...

This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $2.196 billion contract is for the Vaccines for Children (VFC) program and covers the purchase of standard commercial pediatric vaccines from April 1, 2025, through March 31, 2026. The VFC program provides free vaccines to eligible children, including those who are...

The Centers for Disease Control and Prevention (CDC) has awarded a $2,208,581,100 Indefinite Delivery Contract (IDC) to Pfizer Inc. for the Vaccines for Children (VFC) program. This multiple-award IDC will provide standard commercial pediatric vaccines to support immunization efforts for eligible children, including those who are Medicaid-eligible, uninsured, American Indian/Alaska Native, or have insurance that does not cover vaccines. The contract period spans from April 1, 2025, to March...

This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., is for the provision of vaccines for the Vaccines for Children (VFC) program. Valued at up to $2,413,810,030, the 5-year contract (4/1/2023 - 3/31/2024) is a multiple award vehicle that allows the CDC to issue task orders for a variety of vaccine products and related services from the prime contractor. Sanofi Pasteur, as a leading global vaccine manufacturer, will leverage...

This is an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccine production. The contract, with a ceiling value of $1,537,821,800, is for the procurement of 20 standard pediatric vaccines to support immunization programs under the Vaccines for Children (VFC) program and Section 317(j) of the Public Health Service Act. The period of performance is...

This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC as the prime contractor. The contract, valued at up to $1.25 billion, is part of the Vaccines for Children (VFC) 2015 program and provides for the delivery of various vaccines and pharmaceutical products to support federal immunization and disease prevention initiatives. Key products and services included under this multiple award IDV contract include seasonal influenza...

This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer, to procure a variety of pediatric vaccines for the Vaccines for Children (VFC) program. The contract has a ceiling value of $1,914,795,500.00 and a period of performance from April 1, 2024 through March 31, 2025. The solicitation sought offers for 27 different pediatric vaccines including vaccines for diseases such as dengue, diphtheria,...

The provided information describes an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a leading global pharmaceutical corporation. The $425.5 million IDC, with a period of performance running from June 2023 to June 2024, is for the procurement of adult COVID-19 vaccines. As a major supplier of pharmaceutical products and vaccines to the U.S. federal government, Pfizer holds several significant Indefinite Delivery Vehicles (IDVs),...